This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Genetic Technology Alert. Nanoparticle-Based Wound Therapy Developed; Cancer Drug Found To Be Effective in Treating Arterio-Venous Malformations; Gene Responsible for Insulin Resistance Discovered

Genetic Technology Alert. Nanoparticle-Based Wound Therapy Developed; Cancer Drug Found To Be Effective in Treating Arterio-Venous Malformations; Gene Responsible for Insulin Resistance Discovered

RELEASE DATE
03-Apr-2015
REGION
Global
Deliverable Type
Technology Alert
Research Code: D756-00-8C-00-00
SKU: HC02707-GL-TA_19601
$250.00
In stock
SKU
HC02707-GL-TA_19601
$250.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This issue profiles a nanoparticle-based wound therapy, a cancer drug found to be effective in treating arterio-venous malformations, and a gene responsible for insulin resistance.

Table of Contents

In This Issue

  • 1. NANOPARTICLE-BASED WOUND THERAPY DEVELOPED
  • 2. CANCER DRUG FOUND TO BE EFFECTIVE IN TREATING ARTERIO-VENOUS MALFORMATIONS
  • 3. GENE RESPONSIBLE FOR INSULIN RESISTANCE DISCOVERED
  • 4. GLOBAL PATENTS ON TREATMENT OPTIONS FOR PRADER-WILLI SYNDROME
Request Sample
Popular Topics

diabetes market

wound care market

cloud security market

industrial robotics market

smart wearables market

neuromodulation market

vaccine market

video analytics market

glucose monitoring devices market

medical robots market

This issue profiles a nanoparticle-based wound therapy, a cancer drug found to be effective in treating arterio-venous malformations, and a gene responsible for insulin resistance.
More Information
Deliverable Types Technology Alert
No Index No
Podcast No
Industries Healthcare
WIP Number D756-00-8C-00-00
Is Prebook No
Ti Codes D758